Alignment Healthcare/$ALHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alignment Healthcare
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Ticker
$ALHC
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
1,679
ISIN
US01625V1044
Website
ALHC Metrics
BasicAdvanced
$2.7B
-
-$0.47
1.32
-
Price and volume
Market cap
$2.7B
Beta
1.32
52-week high
$21.06
52-week low
$7.44
Average daily volume
3.2M
Financial strength
Current ratio
1.694
Quick ratio
1.517
Long term debt to equity
302.31
Total debt to equity
302.31
Interest coverage (TTM)
-2.81%
Profitability
EBITDA (TTM)
-33.915
Gross margin (TTM)
11.57%
Net profit margin (TTM)
-3.02%
Operating margin (TTM)
-2.06%
Effective tax rate (TTM)
-0.05%
Revenue per employee (TTM)
$1,790,000
Management effectiveness
Return on assets (TTM)
-5.06%
Return on equity (TTM)
-75.39%
Valuation
Price to revenue (TTM)
0.886
Price to book
25.32
Price to tangible book (TTM)
39.45
Price to free cash flow (TTM)
139.367
Free cash flow yield (TTM)
0.72%
Free cash flow per share (TTM)
9.94%
Growth
Revenue change (TTM)
49.12%
Earnings per share change (TTM)
-43.65%
3-year revenue growth (CAGR)
34.05%
3-year earnings per share growth (CAGR)
-22.30%
What the Analysts think about ALHC
Analyst ratings (Buy, Hold, Sell) for Alignment Healthcare stock.
Bulls say / Bears say
Alignment Healthcare's health plan membership reached 189,100 as of December 31, 2024, marking a 58.6% increase year-over-year, indicating strong market demand and effective member acquisition strategies. (stocktitan.net)
Stifel analysts raised the company's price target from $14.00 to $16.00, citing robust Annual Enrollment Period results and reaffirmed guidance for 2024 and 2025, reflecting confidence in the company's growth trajectory. (investing.com)
Bank of America Securities upgraded Alignment Healthcare to a Buy rating with an $11.00 price target, highlighting the company's shift from growth to margin focus and potential for significant earnings per share growth by 2027. (markets.businessinsider.com)
Despite strong revenue growth, Alignment Healthcare reported a net loss of $(128.1) million for the full year 2024, indicating ongoing profitability challenges. (stocktitan.net)
Analysts from Stephens initiated coverage with an Equal Weight rating and a $9 price target, expressing caution until more concrete signs of sustainable Adjusted EBITDA profitability emerge. (markets.businessinsider.com)
T. Rowe Price Investment Management reduced its stake in Alignment Healthcare by selling 2,443,795 shares, potentially signaling decreased confidence from institutional investors. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
ALHC Financial Performance
Revenues and expenses
ALHC Earnings Performance
Company profitability
ALHC News
AllArticlesVideos
Alignment Healthcare Founder and CEO John Kao Named to AHIP Board
GlobeNewsWire·3 weeks ago
Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference
GlobeNewsWire·1 month ago
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alignment Healthcare stock?
Alignment Healthcare (ALHC) has a market cap of $2.7B as of June 30, 2025.
What is the P/E ratio for Alignment Healthcare stock?
The price to earnings (P/E) ratio for Alignment Healthcare (ALHC) stock is 0 as of June 30, 2025.
Does Alignment Healthcare stock pay dividends?
No, Alignment Healthcare (ALHC) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Alignment Healthcare dividend payment date?
Alignment Healthcare (ALHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Alignment Healthcare?
Alignment Healthcare (ALHC) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.